You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
樂普生物-B(02157.HK)完成配售9382.5萬股 淨籌4.63億港元

格隆匯7月11日丨樂普生物-B(02157.HK)宣佈,配售協議所載的配售事項的所有條件(包括(其中包括)上市委員會批準配售股份上市及買賣)均已獲達成,且配售事項已於2025年7月11日完成。

公司已成功按配售價每股配售股份5.02港元向不少於6名承配人配售合共9382.5萬股配售股份,分別佔經配發及發行配售股份擴大後的全部已發行H股及全部已發行股份約5.36%及5.20%。

配售事項所得款項總額及所得款項總淨額將分別爲約4.71億港元及約4.6294億港元。配售事項所得款項淨額(i)約20%將用於投資公司核心產品MRG003(EGFR-ADC)的商業化及市場推廣;(ii)約60%用於公司核心產品的臨牀試驗推進;及(iii)約20%用於新產品管線的研發。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account